SMN1 and proximal spinal muscular atrophy: In addition to affecting motor neurons, SMN pathogenic variants also affect various other systems such as skeletal muscle, heart, kidney, liver, pancreas, spleen, bone, connective tissues, and immune system thereby potentially impacting the metabolism of SMA patients [5, 6].